Predict your next investment

HEALTHCARE | Biotechnology
eribispharma.se

See what CB Insights has to offer

Stage

Seed | Alive

About Eribis Pharmaceuticals

Developer of drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, and also for surgical preconditioning. The company is based on research in the fields of peptide chemistry and pharmacology. Their main goal is to develop drug candidates to meet the market's demand for new and improved treatment in the field of cardio-protection.

Eribis Pharmaceuticals Headquarter Location

Virdings Alle 32B

Uppsala, 754 50,

Sweden

46 7 320 96 32 6

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.